Insulin Ultralente

Insulin Ultralente: description, application and features

Insulin Ultralente is a drug that belongs to the group of long- and extra-long-acting insulins. It is produced by Novo Nordisk A/O (Denmark) and Torrent Pharmaceuticals (India), and is used to treat diabetes.

Description

Insulin Ultralente has the international name Insulin-DlD. Its synonyms include Insulin Superlente, Insulin Ultralente "VO-S", Insulin Ultralente "HO-S", Insulin Ultralente MC, Insulin-Long SMC, Insulin-Long SMP, Insulin-Long suspension, Insulin-Ultralong SMC, Insulin-Ultralong SMP , Insulin-Ultralong suspension, Humulin Ultralen.

The drug is available in the form of a suspension for injection 40 units/ml. It contains the main active ingredient - insulin glargine, which provides stable insulin levels for a long time.

Application

Insulin Ultralente is used to treat diabetes mellitus in adults and children. It has a long-lasting and stable effect, providing a constant level of insulin in the blood for 24 hours. This helps control blood glucose levels and prevent complications associated with diabetes.

Peculiarities

Insulin Ultralente has several features that should be taken into account when using it:

1. The drug must be injected subcutaneously, usually into the abdomen or thigh.
2. The dosage of the drug should be determined individually for each patient depending on his insulin needs.
3. When using Insulin Ultralente, you must regularly monitor your blood glucose levels to maintain stable insulin levels.
4. Before using the drug, you must read the instructions and follow your doctor's recommendations.

In conclusion, Insulin Ultralente is an effective drug for the treatment of diabetes mellitus, which ensures stable insulin levels in the blood for a long time. However, before using it, you should consult your doctor and read the instructions.